UniCel DxI 600, 800 Access Immunoassay System — recall 59020
Health Canada — Medical Devices · Canada · 2019-03-08 · Type III
As described by Health Canada — Medical Devices: UniCel DxI 600, 800 Access Immunoassay System - Thyroglobulin Antibody II (2019-02-09)
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Beckman Coulter has determined through customer feedback and an internal investigation that the four affected access thyroglobulin antibody II (TgAbII) reagent lots may generate falsely decreased results in some patient samples when compared to previously released reagent lots. The affected lots of TgAbII reagent have been shown to generate repeatable (falsely decreased) results by up to 95% in some patient samples.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.